Structural Forms of Phenprocoumon and Warfarin That Are Metabolized at the Active Site of CYP2C9

By He M.   Korzekwa K.R.   Jones J.P.   Rettie A.E.   Trager W.F.  

Archives of Biochemistry and Biophysics, Vol. 372, Iss. 1, 1999-12 ,pp. : 16-28

Elsevier

Access to resources Recommend Favorite

Bioactivation of chlorpyrifos by CYP2B6 variants

By Crane Alice L.   Klein Kathrin   Olson James R.  

Xenobiotica, Vol. 42, Iss. 12, 2012-12 ,pp. : 1255-1262

Informa Healthcare

Access to resources Recommend Favorite

Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study

By Vicente Jorge   González-Andrade Fabricio   Soriano Antonia   Fanlo Ana   Martínez-Jarreta Begoña   Sinués Blanca  

Molecular Biology Reports, Vol. 41, Iss. 3, 2014-03 ,pp. : 1267-1272

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic studies of enantiomers of ibuprofen and its chiral metabolites in humans with different variants of genes coding CYP2C8 and CYP2C9 isoenzymes

By Karazniewicz-łada M.   łuczak M.   Głowka F.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 476-485

Informa Healthcare

Access to resources Recommend Favorite

Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development

By Mori K.   Hashimoto H.   Takatsu H.   Tsuda-Tsukimoto M.   Kume T.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 415-422

Informa Healthcare

Access to resources Recommend Favorite